Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zymosense
AddedFeb 19, 2024
UpdatedJun 18, 2026
Zymosense

Zymosense

Angel

Zymosense, an Iowa-based software company, automates extraction and sorting of chiral-pure carbon nanotubes.

HQ
Ames, IA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded in Ames, Iowa, Zymosense focuses on automating the extraction and sorting of chiral-pure single-walled carbon nanotubes. The company's core mission is to provide low-cost and scalable solutions for industries requiring precise nanotube separation. Their flagship product leverages the NIST-developed aqueous two-phase extraction system, enabling rapid evaluation, discovery, and design of new enzymes. Zymosense aims to revolutionize various sectors by making advanced nanotube technology more accessible.

Notable figures affiliated with Zymosense include experts in nanotechnology and software automation, though specific names are not disclosed. The company has achieved significant milestones in demonstrating proof-of-concept for their automated systems. Their impact is evident in the enhanced efficiency and reduced costs for industries utilizing chiral-pure nanotubes, positioning Zymosense as a key player in the nanotechnology market.

Zymosense - Similar Companies

Zymeron logo

Zymeron

zymeron.com

Zenso logo

Zenso

zensolabs.com

Zenomics logo

Zenomics

Inzio logo

Inzio

Zense logo

Zense

zense-life.com

Izote Biosciences logo

Izote Biosciences

izote.bio

Zymo Interactive logo

Zymo Interactive

Zymochem logo

Zymochem

zymochem.com

Zync logo

Zync

InspectoBot logo

InspectoBot

inspectobot.com

ZenoLink logo

ZenoLink

Zymtech Production logo

Zymtech Production

MouSensor logo

MouSensor

mousensor.com

Zentyment logo

Zentyment

zentyment.com

AthemBio logo

AthemBio

athembio.com

Zymosense - Quick Facts

Who are Zymosense's competitors?

Companies similar to Zymosense include Zymeron, Zenso, Zenomics and Inzio.

When was Zymosense founded?

Zymosense was founded in 2021.

Where is Zymosense's headquarters located?

Zymosense's headquarters is located in Ames, IA, US.

How much has Zymosense raised to-date?

As of Jun 29, 2022, Zymosense has raised a total of $256k (USD).

How many employees does Zymosense have?

Zymosense has 5 employees as of Feb 4, 2024.

Zymosense - Classification

Technology
  • Automation
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Software
Tags
  • Nanotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software